Influence of 'nonhematological' doses of erythropoietin on lipid-carbohydrate metabolism and life quality in hemodialysis patients.
Manitius
J
J
Szołkiewicz
M
M
Myśliwska
J
J
Zorena
K
K
Myśliwski
A
A
Jakubowski
Z
Z
Lysiak-Szydłowska
W
W
Rutkowski
B
B
D000740:Anemia / Q000188:drug therapy; D050260:Carbohydrate Metabolism; D004305:Dose-Response Relationship, Drug; D004920:Erythropoiesis / Q000187:drug effects; D004921:Erythropoietin / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D050356:Lipid Metabolism; D008297:Male; D011788:Quality of Life; D006435:Renal Dialysis / Q000009:adverse effects
D004921:Erythropoietin